Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Early detection research program at the NCI

S Srivastava1, S C Rossi

  • 1Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD 20892, USA.

International Journal of Cancer
|February 20, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Communication: Unusual dynamics of hybrid nanoparticles and their binary mixtures.

The Journal of chemical physics·2010
Same author

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.

Prostate cancer and prostatic diseases·2010
Same author

Interleukin-18: biology and role in the immunotherapy of cancer.

Current medicinal chemistry·2010
Same author

Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi.

Acta tropica·2010
Same author

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.

Prostate cancer and prostatic diseases·2010
Same author

Simple ultraviolet calibration source with reference spectra and its use with the Galileo orbiter ultraviolet spectrometer.

Applied optics·2010
Same journal

Leveraging Minimal Variables for Maximal Screening Yield: A Global Equity Perspective on Colorectal Cancer Risk Stratification.

International journal of cancer·2026
Same journal

Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.

International journal of cancer·2026
Same journal

Cancer Survival for Selected Cancers in Türkiye (2008-2017): A Population-Based Study.

International journal of cancer·2026
Same journal

Cardiovascular-Kidney-Metabolic Syndrome, Healthy Lifestyles, and Risk of Cancer Incidence and Mortality: A Prospective Cohort Study.

International journal of cancer·2026
Same journal

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

International journal of cancer·2026
Same journal

Asymptomatic Cardiotoxicity After High-Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography.

International journal of cancer·2026
See all related articles

The Early Detection Research Network (EDRN) supports research to find new biomarkers for early cancer detection. This network aims to improve screening and risk assessment for multiple cancer types.

Area of Science:

  • Oncology
  • Biomarker Research
  • Cancer Prevention

Background:

  • The National Cancer Institute established the Early Detection Research Network (EDRN).
  • EDRN focuses on translational research for early cancer detection.
  • Early detection is crucial for improving patient outcomes and survival rates.

Purpose of the Study:

  • To establish a collaborative network for biomarker research in early cancer detection.
  • To deepen the understanding of molecular tumorigenesis in cancer screening and risk assessment.
  • To identify and validate biomarkers for cancer screening studies and clinical application.

Main Methods:

  • Establishing a network of research institutions with relevant expertise and resources.
  • Conducting translational research focused on molecular and genetic markers.

Related Experiment Videos

  • Investigating biomarkers for specific cancers including prostate, colorectal, lung, head and neck, bladder, and breast.

    • Main Results:

    • The EDRN program facilitates collaborative biomarker research across multiple institutions.
    • Progress is being made in understanding the molecular basis of cancer development.
    • The network is identifying potential biomarkers for various cancer types.

    Conclusions:

    • The EDRN is a vital initiative supporting the development of novel early cancer detection strategies.
    • Continued research into biomarkers is essential for advancing cancer screening and risk assessment.
    • The network's collaborative approach accelerates the translation of research findings into clinical practice.